DXN, a Malaysian direct selling firm, is constructing a production plant for neutraceuticals, cosmetics, and toiletries near Siddipet, India.
Business with Ganoderma
The firm, based in Malaysia, is recognized for its Ganoderma business, including nutritional supplements, food and beverage, personal care, skincare and cosmetics, household goods, and water treatment systems among its product lines.
Noni (Morinda citrifolia) production is outsourced to local farmers, who sell the products to the firm for use in the creation of neutraceuticals.
From India to Asia as a whole
“Around Rs 250-300 crore is expected to be invested in the entire facility. The goods would be manufactured for the Indian market in the initial phase. In a statement to the local press, KM Rafique, Director of International Marketing at DXN, said, “We also have plans to progressively sell to Sri Lanka, Bangladesh, and Nepal.”
Assisting local agriculture
“We will provide farmers with expertise about noni cultivation, which is one of our important components. We’ll provide you with a buyback service. We will also urge local farmers to cultivate spirulina in the latter phases, ” he added, adding that the entire installation would take around six months to complete, while the factory would take a month.
“Machine has been put on site,” he added, adding that the plant will employ 800 to 1,000 people in the area.
MSMEs are aided.
Rafique stated that the firm will require a significant amount of packaging material, which would be acquired locally. “Direct selling helps the packing, courier, and logistics industries,” he explained.
Telangana is one of the states that has accepted the Center for the Direct Selling Industry’s Model Guidelines to safeguard customers’ interests. “We are hoping that some businesses would choose Telangana as a location for their production units,” said Jayesh Ranjan, Chief Industries Secretary.
Heading 2: DXN, a direct selling company, has announced the opening of a new product factory in India.
